SB 140Session 2025
TO MANDATE THE USE OF BIOSIMILAR MEDICINES UNDER HEALTH BENEFIT PLANS; TO REQUIRE A HEALTHCARE PROVIDER TO PRESCRIBE BIOSIMILAR MEDICINES; AND TO IMPROVE ACCESS TO BIOSIMILAR MEDICINES.
Progress
- Introduced
- In committee
- Passed one chamber Not yet
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
Legislative history
-
Senate
Sine Die adjournment
-
Senate
Recommended for study in the Interim Committee on INSURANCE & COMMERCE - SENATE
-
Senate
Withdrawn from Committee and placed on calendar.
-
Senate
Re-referred to INSURANCE & COMMERCE - SENATE
-
Senate
REPORTED CORRECTLY ENGROSSED
-
Senate
Amendment # 2 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
-
Senate
Withdrawn from Committee and placed on 2nd reading for purpose of amendment # 2
-
Senate
Re-referred to INSURANCE & COMMERCE - SENATE
-
Senate
REPORTED CORRECTLY ENGROSSED
-
Senate
Amendment # 1 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
-
Senate
Withdrawn from Committee and placed on 2nd reading for purpose of amendment # 1
-
Senate
Read first time, rules suspended, read second time, referred to INSURANCE & COMMERCE - SENATE
-
Senate
Filed